CIAM
ADMA icon

Caitong International Asset Management’s ADMA Biologics ADMA Stock Holding History

Caitong International Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2K Sell
2,890
-110,047
-97% -$1M ﹤0.01% 930
2026
Q1 		$1.02M Buy
+112,937
New +$1.78M 0.19% 119
2025
Q4 		– Sell
-68
Closed -$997 – 1843
2025
Q3 		$997 Buy
+68
New +$1.17K ﹤0.01% 1463
2025
Q1 		– Sell
-2,983
Closed -$51.2K – 2127
2024
Q4 		$51.2K Buy
+2,983
New +$56.1K 0.05% 474

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Caitong International Asset Management's ADMA Position: Q2 2026 in Review

Caitong International Asset Management reduced its ADMA Biologics (ADMA) stake by 97% in Q2 2026, selling an estimated $1M and leaving 2,890 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Caitong International Asset Management first reported a position in ADMA in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.02M in Q1 2026. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Caitong International Asset Management held 2,890 shares of ADMA Biologics worth $24.2K as of Q2 2026.
  • Caitong International Asset Management sold 110,047 ADMA Biologics shares in Q2 2026, an estimated $1M.
  • ADMA Biologics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #930 holding.
  • Caitong International Asset Management first reported a position in ADMA Biologics in Q4 2024 and has held it in 4 quarters since.
  • Caitong International Asset Management's ADMA Biologics position peaked at $1.02M in Q1 2026.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.